news Largest genome sequencing project launched in UK 13 September 2019 | By Victoria Rees (Drug Target Review) The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
news Collaboration to discover MND treatments announced 27 August 2019 | By Victoria Rees (Drug Target Review) MSD and the Francis Crick Institute will work together on a project to identify disease targets for motor neuron disease.
news Molecule found to boost immune cells leads to new cancer therapy target 29 May 2019 | By Drug Target Review A study has identified a molecule which boosts immune cell function and could be used in cancer therapies.
news Targeted oral treatments for severe asthma 22 January 2019 | By Iqra Farooq (Drug Target Review) Researchers are aiming to identify whether antibiotics could be used to treat severe asthma in place of steroids which often have unwanted side effects...
news Human antibody discovery could save lives from fungal killer 12 December 2018 | By Drug Target Review Novel therapy uses antibodies cloned from patients who have recovered from an infection caused by the fungus Candida…
news Derm-BOT compound relieves chronic pain 23 July 2018 | By Dr Zara Kassam (Drug Target Review) A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects...
news Mitochondrial disease can be inherited from healthy parents 15 January 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have shown for the first time how children can inherit a severe -- potentially fatal - mitochondrial disease from a healthy mother...
news New weakness found in most common childhood malignant brain tumour 7 December 2017 | By Drug Target Review A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
news Lung study in mice points to new therapies to treat critical illness 10 May 2017 | By Niamh Marriott (Drug Target Review) Scientists have pinpointed a chemical signal that worsens inflammation linked to a life-threatening lung condition. The discovery could eventually lead to new therapies for this disease, which can be fatal for up to half of those affected.
news Naturally occurring genetic variation gives complete resistance in prion diseases 11 June 2015 | By Victoria White Researchers have identified a naturally occurring variant of the human prion protein that produces resistance to prion diseases such as CJD...
news MRC and UCB collaborate to offer access to UCB’s novel antibody discovery platform 30 March 2015 | By Victoria White The MRC and UCB are to launch a collaboration that will provide scientists with access to cutting-edge technologies to discover new monoclonal antibodies...
news Medical breakthroughs on the horizon with £32m boost from the Biomedical Catalyst 26 March 2015 | By Victoria White New treatments, diagnostics and medical technologies are set to benefit from an investment of £32 million through the Biomedical Catalyst...
news Combination cell-gene therapy for lung cancer to be tested in UK patients 6 March 2015 | By The Medical Research Council A pioneering new combined cell-gene therapy to treat lung cancer will be tested in NHS patients this year, after receiving £2m of Biomedical Catalyst funding from the Medical Research Council...
news Minister announces £14m investment in stratified medicine 29 January 2015 | By Medical Research Council Minister for Life Sciences George Freeman announced a further £13.7 million investment in stratified medicine collaborations funded by the Medical Research Council (MRC)...
news World’s first artificial enzymes created using synthetic biology 2 December 2014 | By The Medical Research Council Medical Research Council scientists have created the world’s first enzymes made from artificial genetic material...
